Variability of repeated serum prostate-specific antigen (psa) measurements within less than 90 days in a well-defined patient population-Reference-Cited by-同舟云学术

Variability of repeated serum prostate-specific antigen (psa) measurements within less than 90 days in a well-defined patient population

Published:1996-01 Issue:1 Volume:47 Page:59-66
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Roehrborn Claus G.,Pickens G. John,Carmody Thomas

Publisher

Elsevier BV

Subject

Urology

Reference10 articles.

1. Short-term and long-term intra-individual variations and critical differences of clinical chemistry laboratory parameters;Costongs;J Clin Chem Clin Biochem,1985

2. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate;Oesterling;J Urol,1991

3. Serum prostate-specific antigen discriminates weakly between men with benign prostatic hyperplasia and patients with organconfined prostate cancer;Sershon;Eur Urol,1994

4. Barry MJ and Oesterling JE: Prostate specific antigen cannot distinguish stage T1a (A1) prostate cancer from benign prostatic hyperplasia;Monda;J Urol,1994

5. The effect of digital rectal examination on the serum prostate specific antigen concentration: results of a randomized study;Chybowski;J Urol,1992

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new promising indicator in prostate cancer screening: Prostate-specific antigen fluctuation rate;Actas Urológicas Españolas (English Edition);2024-07

2. Tasa de fluctuación del PSA: un indicador prometedor para el cribado del cáncer de próstata;Actas Urológicas Españolas;2023-12

3. Utility of noninvasive biomarker testing and MRI to predict a prostate cancer diagnosis;International Urology and Nephrology;2023-09-24

4. Prostate-specific antigen kinetics contributes to decision making for biopsy referral: the predictive implication for PSA retest in patients with elevated PSA levels;Prostate International;2023-03

5. Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial;Cancers;2021-04-20